Hrt Financial LP Biotechnology

Hrt Financial LP

$18.1 Billion
Q3 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
GLPG Galapagos Nv	$1.69B	$467,000 0.0% of portfolio	16,241	Q3 2024 New
LQDA Liquidia Corp	$785M	$419,000 0.0% of portfolio	41,945	Q3 2024 Added 285.31%
VRCA Verrica Pharmaceuticals Inc.	$327M	$385,000 0.0% of portfolio	48,483	Q3 2024 New
BNTX Bio N Tech Se	$29.8B	$380,000 0.0% of portfolio	3,201	Q3 2024 New
VIR Vir Biotechnology, Inc.	$1.6B	$367,000 0.0% of portfolio	49,022	Q3 2024 Added 38.85%
KROS Keros Therapeutics, Inc.	$375M	$337,000 0.0% of portfolio	5,807	Q3 2024 New
ABCL Ab Cellera Biologics Inc.	$833M	$336,000 0.0% of portfolio	129,904	Q3 2024 New
ZNTL Zentalis Pharmaceuticals, Inc.	$157M	$289,000 0.0% of portfolio	78,927	Q3 2024 New
HUMA Humacyte, Inc.	$475M	$268,000 0.0% of portfolio	49,416	Q3 2024 New
AMLX Amylyx Pharmaceuticals, Inc.	$205M	$263,000 0.0% of portfolio	81,291	Q3 2024 Added 175.16%
ADPT Adaptive Biotechnologies Corp	$929M	$230,000 0.0% of portfolio	44,969	Q3 2024 New
ALEC Alector, Inc.	$149M	$230,000 0.0% of portfolio	49,363	Q3 2024 New
GLUE Monte Rosa Therapeutics, Inc.	$266M	$206,000 0.0% of portfolio	38,911	Q3 2024 New
IMCR Immunocore Holdings PLC	$1.33B	$201,000 0.0% of portfolio	6,479	Q3 2024 New
TERN Terns Pharmaceuticals, Inc.	$191M	$197,000 0.0% of portfolio	23,637	Q3 2024 New
YMAB Y M Abs Therapeutics, Inc.	$301M	$187,000 0.0% of portfolio	14,260	Q3 2024 New
BCRX Biocryst Pharmaceuticals Inc	$1.43B	$152,000 0.0% of portfolio	20,044	Q3 2024 New
THRD Third Harmonic Bio, Inc.	$337M	$152,000 0.0% of portfolio	11,259	Q3 2024 New
STOK Stoke Therapeutics, Inc.	$355M	$146,000 0.0% of portfolio	11,955	Q3 2024 New
QURE Uni Qure N.V.	$647M	$128,000 0.0% of portfolio	26,014	Q3 2024 New
PGEN Precigen, Inc.	$246M	$108,000 0.0% of portfolio	114,461	Q3 2024 New
NTRB Nutri Band Inc.	$34.2M	$64,000 0.0% of portfolio	10,662	Q3 2024 New
CTMX Cytom X Therapeutics, Inc.	$58M	$31,000 0.0% of portfolio	26,840	Q3 2024 New
LEXX Lexaria Bioscience Corp.	$12.9M	$31,000 0.0% of portfolio	10,257	Q3 2024 New
VIRX Viracta Therapeutics, Inc.	$7.14M	$31,000 0.0% of portfolio	138,822	Q3 2024 New
ATAI Atai Life Sciences N.V.	$249M	$31,000 0.0% of portfolio	27,524	Q3 2024 New
IOBT Io Biotech, Inc.	$25.1M	$27,000 0.0% of portfolio	26,646	Q3 2024 New
HCWB Hcw Biologics Inc.	$14M	$25,000 0.0% of portfolio	46,497	Q3 2024 Reduced 30.25%
CMMB Chemomab Therapeutics Ltd.	$24.2M	$21,000 0.0% of portfolio	13,579	Q3 2024 New
CTXR Citius Pharmaceuticals, Inc.	$530M	$18,000 0.0% of portfolio	37,182	Q3 2024 Reduced 62.85%
AMRN Amarin Corp Plcuk	$222M	$16,000 0.0% of portfolio	25,900	Q3 2024 Added 74.5%
EQ Equillium, Inc.	$24M	$14,000 0.0% of portfolio	18,064	Q3 2024 Reduced 40.79%
VIRI Virios Therapeutics, Inc.	$81.4M	$13,000 0.0% of portfolio	81,574	Q3 2024 Added 41.76%
VINC Vincerx Pharma, Inc.	$4.24M	$10,000 0.0% of portfolio	14,701	Q3 2024 New
AIM Aim Immuno Tech Inc.	$10.1M	$9,000 0.0% of portfolio	34,744	Q3 2024 New
INM In Med Pharmaceuticals Inc.	$4.08M	$9,000 0.0% of portfolio	38,369	Q3 2024 Added 139.87%
KZR Kezar Life Sciences, Inc.	$445M	$8,000 0.0% of portfolio	10,961	Q3 2024 Reduced 85.9%
GLYC Glycomimetics Inc	$13.6M	$5,000 0.0% of portfolio	32,324	Q3 2024 Reduced 32.21%
INAB In8 Bio, Inc.	$8.33M	$3,000 0.0% of portfolio	11,252	Q3 2024 Added 4.06%

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.